Topical Alpha-Agonist Therapy for Persistent Facial Erythema of Rosacea and the Addition of Oxmetazoline to the Treatment Armamentarium: Where Are We Now? July 1, 2017 by James Q. Del Rosso, DO, FAOCD, FAAD Dr. Del Rosso is CONTINUE READING »
